Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-01-26 to 2022-02-16
Current total value of award: $2558
Description: 4556102811!ZOLADEX 3.6 MG IMPLANT SYRNS